218150 — Milae Bioresources Co Income Statement
0.000.00%
Last trade - 00:00
- KR₩96bn
- KR₩77bn
- KR₩60bn
- 63
- 23
- 22
- 24
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 50,079 | 47,497 | 66,668 | 75,635 | 60,016 |
Cost of Revenue | |||||
Gross Profit | 6,332 | 6,790 | 8,480 | 9,527 | 8,205 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 48,614 | 46,082 | 64,813 | 74,053 | 60,215 |
Operating Profit | 1,465 | 1,415 | 1,855 | 1,582 | -199 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 1,250 | 1,034 | 1,144 | 905 | 393 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1,030 | 953 | 1,079 | 878 | 359 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 1,030 | 955 | 1,015 | 963 | 441 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1,030 | 955 | 1,015 | 963 | 441 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 57.9 | 53.7 | 57 | 50.8 | 33 |
Dividends per Share |